14
0Kirin Holdings Company, Limited, established in 1907, is a world-leading global group headquartered in Japan. Under its corporate slogan, "Joy brings us together," the company leverages its foundational fermentation and biotechnology expertise to expand new joys of "Food and Well-being" and contribute to a joyful society. Kirin has built a unique business portfolio consisting of four core segments: Alcoholic Beverages (such as its flagship beer brands), Non-Alcoholic Beverages, Pharmaceuticals, and its rapidly growing Health Science business, which fully integrates acquired leaders like FANCL and Blackmores. In fiscal year 2025, the Kirin Group delivered record-high financial performance, achieving consolidated revenue of 2,433.4 billion yen and a normalized business profit of 251.8 billion yen.
Under the "Innovate 2035!" vision, Kirin aims to create a future for well-being. A key driver is its Health Science segment, which achieved profitability in 2025 with a business profit of 11.1 billion yen. Kirin plans to accelerate the Asia-Pacific expansion of FANCL and Blackmores alongside proprietary ingredients like LC-Plasma. For FY2026, Kirin forecasts revenue of 2,480.0 billion yen, business profit of 235.0 billion yen, and profit of 156.0 billion yen. The long-term financial targets seek high single-digit EPS CAGR, ROIC above 10%, and a market capitalization of 3 trillion yen.
The audio and written content of this podcast are intended to help listeners understand the general business conditions and publicly available information of major listed companies in Japan. They do not constitute investment advice, investment recommendations, or investment solicitations.
